CG

Chhama Gaur

Active Director Director DIN 08747101
DIN 08747101 First appointment May 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2020
Shareholding value •••• Premium profile

About Chhama Gaur

Data last updated:

Chhama Gaur is a Director at Accure Medical Private Limited (since 2020). The company operates in Pharma. Accure Medical Private Limited reported revenue of ₹14.97 Cr (FY 2024).

DIN 08747101
Primary Designation Director
Industry Pharma
First Appointment 26 May 2020
Oldest Company Age 6 yrs
Largest company Accure Medical Private Limited · ₹14.97 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Accure Medical Private Limited U52603UP2020PTC236390
Director26 May 20202020₹14.97 Cr (FY 2024)Active

Board colleagues of Chhama Gaur

NameDINCompanyDesignation
Prashant Sharma08056009Accure Medical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Accure Medical Private Limited
Premium access

Shareholding and investment profile for Chhama Gaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chhama Gaur

Chhama Gaur currently holds 1 directorship: Accure Medical Private Limited (Director, since 26 May 2020, revenue ₹14.97 Cr (FY 2024)).

Chhama Gaur was first appointed on 26 May 2020 as Director at Accure Medical Private Limited.

The current boards of Chhama Gaur's companies include Prashant Sharma (Accure Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available